Strainsforpains Stock EBITDA
| EBYH Stock | USD 0.23 0.00 0.00% |
Strainsforpains fundamentals help investors to digest information that contributes to Strainsforpains' financial success or failures. It also enables traders to predict the movement of Strainsforpains Pink Sheet. The fundamental analysis module provides a way to measure Strainsforpains' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Strainsforpains pink sheet.
Strainsforpains |
Strainsforpains Company EBITDA Analysis
Strainsforpains' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Strainsforpains reported earnings before interest,tax, depreciation and amortization of 0.0. This is 100.0% lower than that of the Oil, Gas & Consumable Fuels sector and about the same as Energy (which currently averages 0.0) industry. The ebitda for all United States stocks is 100.0% higher than that of the company.
Strainsforpains EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Strainsforpains' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Strainsforpains could also be used in its relative valuation, which is a method of valuing Strainsforpains by comparing valuation metrics of similar companies.Strainsforpains is currently under evaluation in ebitda category among its peers.
Strainsforpains Fundamentals
| Current Valuation | 1.56 M | |||
| Price To Earning | (0.87) X | |||
| Net Income | (66.08 K) | |||
| Cash And Equivalents | 2.29 K | |||
| Total Debt | 1.81 M | |||
| Book Value Per Share | (2.94) X | |||
| Cash Flow From Operations | (66.08 K) | |||
| Earnings Per Share | (0.23) X | |||
| Beta | 1.23 | |||
| Market Capitalization | 1.78 M | |||
| Total Asset | 5.04 K | |||
| Retained Earnings | (1.38 M) | |||
| Working Capital | (1.3 M) | |||
| Current Asset | 35 K | |||
| Current Liabilities | 1.34 M | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 5.04 K |
About Strainsforpains Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Strainsforpains's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Strainsforpains using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Strainsforpains based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Strainsforpains Pink Sheet
Strainsforpains financial ratios help investors to determine whether Strainsforpains Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Strainsforpains with respect to the benefits of owning Strainsforpains security.